Interestingly, at least some of these miRs (miR-135a, miR-497) display a reduced expression in cancer (i. e. opposite to ERRα) [33, 42], together suggesting that this reduction may account for the increase in ERRα expression at the mRNA level. The gene discussed is ESRRA; the disease is cancer.